Scarica l'app Stockscreener
6.96
0.14%
0.010
Precedente Chiudi:
$6.95
Aprire:
$6.96
Volume 24 ore:
5.99M
Relative Volume:
0.89
Capitalizzazione di mercato:
$1.23B
Reddito:
$2.59B
Utile/perdita netta:
$-981.73M
Rapporto P/E:
-1.2062
EPS:
-5.77
Flusso di cassa netto:
$206.95M
1 W Prestazione:
+0.29%
1M Prestazione:
-18.21%
6M Prestazione:
-46.25%
1 anno Prestazione:
-3.47%
Intervallo 1D:
$6.85
$7.0975
Intervallo di 1 settimana:
$6.77
$7.15
Portata 52W:
$6.35
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Nome
Teladoc Health Inc
Settore
Industria
Telefono
(203) 635-2002
Indirizzo
155 E 44TH STREET, NEW YORK, NY
Confronta TDOC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
6.96 | 1.24B | 2.59B | -981.73M | 206.95M | -5.77 |
|
VEEV
Veeva Systems Inc
|
282.13 | 46.19B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
60.87 | 9.61B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.58 | 10.89B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
93.05 | 7.86B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
34.59 | 5.92B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-25 | Iniziato | Mizuho | Neutral |
| 2024-11-15 | Iniziato | Goldman | Buy |
| 2024-09-17 | Reiterato | Jefferies | Hold |
| 2024-02-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-17 | Downgrade | DA Davidson | Buy → Neutral |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-04-12 | Iniziato | Stephens | Equal-Weight |
| 2023-02-23 | Aggiornamento | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | Aggiornamento | Guggenheim | Sell → Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-17 | Downgrade | Guggenheim | Neutral → Sell |
| 2022-08-12 | Iniziato | DA Davidson | Buy |
| 2022-08-02 | Downgrade | Berenberg | Buy → Hold |
| 2022-08-02 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-07-28 | Downgrade | Goldman | Buy → Neutral |
| 2022-07-28 | Downgrade | Needham | Buy → Hold |
| 2022-07-06 | Reiterato | BofA Securities | Neutral |
| 2022-05-05 | Downgrade | Argus | Buy → Hold |
| 2022-04-28 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-28 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2022-04-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-04-28 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-03 | Aggiornamento | Argus | Hold → Buy |
| 2022-02-23 | Reiterato | BofA Securities | Neutral |
| 2022-02-23 | Reiterato | Craig Hallum | Hold |
| 2022-02-23 | Reiterato | Evercore ISI | In-line |
| 2022-02-23 | Reiterato | Goldman | Buy |
| 2022-02-23 | Reiterato | JP Morgan | Overweight |
| 2022-02-23 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | Reiterato | Needham | Buy |
| 2022-02-23 | Reiterato | Oppenheimer | Outperform |
| 2022-02-23 | Reiterato | Stifel | Hold |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2022-02-08 | Reiterato | Piper Sandler | Overweight |
| 2021-12-02 | Ripresa | Jefferies | Hold |
| 2021-11-22 | Downgrade | BTIG Research | Buy → Neutral |
| 2021-10-28 | Reiterato | Barclays | Equal Weight |
| 2021-10-28 | Reiterato | BofA Securities | Neutral |
| 2021-10-28 | Reiterato | Canaccord Genuity | Buy |
| 2021-10-28 | Reiterato | Citigroup | Buy |
| 2021-10-28 | Reiterato | Craig Hallum | Hold |
| 2021-10-28 | Reiterato | Needham | Buy |
| 2021-10-28 | Reiterato | Oppenheimer | Outperform |
| 2021-10-28 | Reiterato | Piper Sandler | Overweight |
| 2021-10-28 | Reiterato | UBS | Neutral |
| 2021-10-19 | Iniziato | Wells Fargo | Overweight |
| 2021-08-02 | Downgrade | Argus | Buy → Hold |
| 2021-07-28 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-05-28 | Iniziato | Robert W. Baird | Neutral |
| 2021-04-15 | Iniziato | Needham | Buy |
| 2021-01-07 | Iniziato | BTIG Research | Buy |
| 2020-12-22 | Iniziato | Evercore ISI | In-line |
| 2020-12-07 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | Iniziato | Goldman | Neutral |
| 2020-11-13 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | Iniziato | DA Davidson | Buy |
| 2020-09-02 | Aggiornamento | Berenberg | Hold → Buy |
| 2020-08-17 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | Iniziato | Citigroup | Buy |
| 2020-07-13 | Iniziato | Argus | Buy |
| 2020-07-07 | Iniziato | Stephens | Overweight |
| 2020-04-30 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | Iniziato | SVB Leerink | Outperform |
| 2020-03-31 | Downgrade | Berenberg | Buy → Hold |
| 2020-03-25 | Downgrade | Craig Hallum | Buy → Hold |
| 2020-03-16 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | Iniziato | UBS | Neutral |
| 2020-01-09 | Downgrade | BofA/Merrill | Buy → Neutral |
Mostra tutto
Teladoc Health Inc Borsa (TDOC) Ultime notizie
Teladoc (TDOC) Q2 Revenue Tops Estimates - AOL.com
Telemedicine Technologies Market Size Growth Trends Report 2035 - MarketReports.us
Revolutionizing Success in the Combined Telehealth - openPR.com
Hinge Health's Post-IPO Surge: A Test of Fundamentals in the Digital Therapeutics Gold Rush - AInvest
Amwell's Strategic Reinvention: Can Narrowing EBITDA Losses and Subscription Growth Fuel Long-Term Value in the Mental Health Tech Sector? - AInvest
Unexpected Trends Reshaping the U.S. Telemedicine Market - openPR.com
How the U.S. Telehealth Market Will Evolve by 2032Growth, - openPR.com
Global Telemedicine Market: Unxpected Growth in Digital Healthcare Delivery & Remote Care | 2025-2032 - openPR.com
Global Telehealth Market: Evolving Patient-Centric Platforms Driving Healthcare Transformation | 2025-2032 - openPR.com
Does Teladoc Health Inc. stock perform well during market downturnsHarness the power of proven investment plans - Jammu Links News
What are the technical indicators suggesting about Teladoc Health Inc.Build wealth faster with consistent investment plans - Jammu Links News
Teladoc Health Q2 Loss Narrower Than Expected on Declining Expenses - MSN
How strong is Teladoc Health Inc. company’s balance sheetOutstanding capital appreciation - Jammu Links News
What is Teladoc Health Inc. company’s growth strategyGet exclusive market insights for better trading - Jammu Links News
What are the latest earnings results for Teladoc Health Inc.Skyrocketing investment returns - Jammu Links News
How volatile is Teladoc Health Inc. stock compared to the marketAchieve rapid portfolio appreciation today - Jammu Links News
Should I hold or sell Teladoc Health Inc. stock in 2025Capitalize on emerging growth stocks - Jammu Links News
How does Teladoc Health Inc. generate profit in a changing economyCapitalize on stocks with high profit margins - Jammu Links News
What makes Teladoc Health Inc. stock price move sharplyCapitalize on market momentum for maximum gains - Jammu Links News
Is Teladoc Health Inc. a growth stock or a value stockMaximize gains with strategic stock entries - Jammu Links News
When is Teladoc Health Inc. stock expected to show significant growthFree Wealth Planning Blueprint - Jammu Links News
What analysts say about Teladoc Health Inc. stockUncover the best stocks for explosive growth - Jammu Links News
What drives Teladoc Health Inc. stock priceMaximize returns with disciplined trading approaches - Jammu Links News
What catalysts could drive Teladoc Health Inc. stock higher in 2025Massive portfolio appreciation - Jammu Links News
Teladoc's Mixed Performance: Solid Integrated Care Growth Amid BetterHelp Challenges and Macroeconomic Pressures. - AInvest
Mixed Analyst Opinions on Healthcare Stocks: Teladoc, Ionis Pharmaceuticals, and Repligen - AInvest
Digital Health Market Set to Witness Significant Growth by 2025-2032 | Teladoc Health, American Well Corporation - openPR.com
Upcoming Opportunities in Pediatric Telehealth Visits Market: - openPR.com
Telehealth Heats Up With Teladoc, Livongo Health $18B Merger - PYMNTS.com
Teladoc Health rises on results beat, guidance announcement - MSN
Teladoc beats Wall Street expectations in Q2 amid strategic revamp - Healthcare Dive
Is it the right time to buy Teladoc Health Inc. stockFinancial News Report For Fast Growth - Jammu Links News
Teladoc Health, Inc. (NYSE:TDOC) Q2 2025 Earnings Call Transcript - Insider Monkey
The Teladoc Health, Inc. (NYSE:TDOC) Second-Quarter Results Are Out And Analysts Have Published New Forecasts - simplywall.st
Analysts Have Made A Financial Statement On Teladoc Health, Inc.'s (NYSE:TDOC) Second-Quarter Report - Yahoo Finance
Teladoc Health likely to post a Q2 loss and year-over-year decline in revenue - MSN
Teladoc Health Inc. stock chart pattern explainedLong Hold Safe Return Strategy Reviewed - metal.it
Teladoc Inc. Earnings Call: Growth Amid Challenges - MSN
Teladoc Health 2025 Q2 Earnings Net Income Surges 96.1% - AInvest
Teladoc (TDOC) Q2 Revenue Tops Estimates - The Motley Fool
Teladoc Health, Inc. SEC 10-Q Report - TradingView
Teladoc (TDOC) Stock Is Up, What You Need To Know - Yahoo Finance
Teladoc Health: Still Struggling To Find A Catalyst (NYSE:TDOC) - Seeking Alpha
Teladoc stock holds steady as Stifel maintains $8 price target By Investing.com - Investing.com Nigeria
Teladoc stock holds steady as Stifel maintains $8 price target - Investing.com
Digital Health Market is evolving rapidly Through 2025 To 2032 | - openPR.com
Teladoc Health Q2 2025 net loss hits USD 32.7 million - Medical Buyer
Needham reiterates Hold rating on Teladoc stock after Q2 results By Investing.com - Investing.com UK
Teladoc Beats Estimates But Faces Sliding Revenue And Mixed Outlook - Finimize
Teladoc Health Earnings: Not Dead Yet (NYSE:TDOC) - Seeking Alpha
Teladoc Health Inc Azioni (TDOC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.97%
6.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):